Tiansheng Pharmaceutical Group issued a notice regarding the abnormal volatility of the company's stock. The company conducted an investigation into the matter and verified the relevant issues regarding the controlling shareholder and actual controller of the company. The details are as follows: There is no need to correct or supplement the information previously disclosed by the company. The company has not found any undisclosed major information that may or has affected the trading price of the company's stocks in the recent public media reports. The current operating situation and internal and external business environment of the company have not undergone any significant changes. Upon investigation, as of the date of the announcement, the company, controlling shareholder and actual controller do not have any significant matters about the company that should be disclosed but have not been disclosed, or significant matters in the planning stage. After investigation, the controlling shareholder and actual controller of the company did not buy or sell the company's stocks during the abnormal volatility in the trading of the company's stocks.
ST天圣：公司、控股股东和实控人不存在关于公司的应披露而未披露的重大事项
Tiansheng Pharmaceutical Group: There are no significant issues about the company that should be disclosed but have not been disclosed by the company, controlling shareholders, or actual controllers.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.